Sotio is a biotechnology company developing a new immunotherapy based on activated dendritic cells for the treatment of cancer.
Sotio has raised $316.6M in total funding. The most recent round was Private Equity. The last funding was announced in December 2021.
Sotio's investors include PPF Group.
Sotio is headquartered in Prague, Czech Republic.
Sotio is a biotechnology company developing a new immunotherapy based on activated dendritic cells for the treatment of cancer.
Sotio is at the Private Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Sotio — Funding & Investors." VCBacked, December 2, 2021, https://www.vcbacked.co/company/sotio. Accessed August 16, 2026.
VCBacked. (2021). Sotio — Funding & Investors. Retrieved August 16, 2026, from https://www.vcbacked.co/company/sotio
{{cite web |title=Sotio — Funding & Investors |url=https://www.vcbacked.co/company/sotio |website=VCBacked |access-date=August 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated